PRISM News
Go To:
Most Recent Stories
PRISM Mid-Day Movers: UK Regulatory Approvals and Positive Data Diverge Indices
PRISM News - Mon Aug 18, 2025
Catheter Precision Surges 53% on UK Approval for LockeT DeviceCatheter Precision, Inc. (VTAK) jumped 52.84% to lead the PRISM Emerging MedDevices Index after securing regulatory approval in the United...
Catheter Precision Expands European Footprint with Key Regulatory Win, LockeT Launch Cleared in the UK, Shares Up 32%
PRISM News - Mon Aug 18, 2025
Catheter Precision (NYSE: VTAK), Inc., a U.S.-based medical device company specializing in advanced products for the cardiac electrophysiology market, has received final approval to market its LockeT product...
Quoin Pharmaceuticals Appoints Sally Lawlor as CFO to Support Commercialization Strategy
PRISM News - Mon Aug 18, 2025
The late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX), announced today the appointment of Sally Lawlor, BCL, FCA, as Chief...
Galaxy Digital Secures $1.4B to Power One of the World's Largest AI Datacenter Campuses
PRISM News - Fri Aug 15, 2025
Galaxy Digital Inc. (GLXY) has closed a massive $1.4 billion project financing facility to accelerate the transformation of its Helios datacenter campus in West Texas into a next-generation hub for AI...
Evolv Technology Lifts 2025 Outlook on Strong Customer Growth and Expanding Recurring Revenue Base
PRISM News - Fri Aug 15, 2025
Evolv Technology (Nasdaq: EVLV) delivered a solid second quarter of 2025, reporting $32.5 million in revenue, a 2% sequential increase and 29% growth over the prior year. The performance was driven by...
CLEAR Opens CLEAR+ Airport Fast Lanes to UK, Canadian, Australian & New Zealand Travelers
PRISM News - Fri Aug 15, 2025
CLEAR (YOU) has expanded its CLEAR+ enrollment to passport holders from the UK, Canada, Australia, and New Zealand, granting them access to expedited security screening at U.S. airports. The move allows...
Coya Therapeutics Q2 Update: Key ALS and Neurodegeneration Catalysts Approaching
PRISM News - Fri Aug 15, 2025
Coya Therapeutics (NASDAQ: COYA), a clinical-stage biotechnology company advancing therapies that enhance regulatory T cell (Treg) function for the treatment of neurodegenerative disorders, reported its...
Catheter Precision Marks Milestone with First LockeT Procedures in Germany
PRISM News - Thu Aug 14, 2025
Catheter Precision, Inc. (NYSE: VTAK), a U.S.-based medical device company specializing in advanced technologies for the cardiac electrophysiology market, has announced the successful completion of the...
BigBear.ai and Smiths Detection Finalize Integration to Boost Airport Security
PRISM News - Thu Aug 14, 2025
BigBear.ai (BBAI) has completed testing and integration of its Pangiam(R) Threat Detection solution with Smiths Detection's HI-SCAN 6040 CTiX computed tomography screening systems, a move aimed at modernizing...
Opus Genetics Reports Strong Q2 Progress with Multiple Clinical Milestones and Expanded Gene Therapy Pipeline
PRISM News - Thu Aug 14, 2025
Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies for inherited retinal diseases (IRDs) and small molecule treatments for other ophthalmic disorders,...
